BAFNAPH

Bafna Pharmaceuticals Share PriceBafna Pharmaceuticals

₹89.55
1.85 (2.11%)
As on 03 December, 2023 | 07:43 BSE: 532989 NSE: BAFNAPHISIN: INE878I01022

Bafna Pharmaceuticals Performance

Day Range

  • Low 87.80
  • High 90.95
₹ 89.55

52 Week Range

  • Low 77.05
  • High 124.45
₹ 89.55
  • Open Price88.80
  • Previous Close87.70
  • Volume8442

Start SIP in Bafna Pharmaceuticals

Start SIP

Bafna Pharmaceuticals Share Price

  • Over 1 Month 3.17%
  • Over 3 Month -12.63%
  • Over 6 Month -20.72%
  • Over 1 Year -13.02%

Bafna Pharmaceuticals Key Statistics

P/E Ratio 12.3
PEG Ratio 0
Market Cap Cr 212
Price to Book Ratio 2.9
EPS 4.7
Dividend 0
Relative Strength Index 55.72
Money Flow Index 74.92
MACD Signal -0.54
Average True Range 3.96

Bafna Pharmaceuticals Investment Rating

  • Master Rating:
  • Bafna Pharmaceuticals has an operating revenue of Rs. 159.09 Cr. on a trailing 12-month basis. An annual revenue growth of 36% is outstanding, Pre-tax margin of 10% is healthy, ROE of 15% is good. The company has a reasonable debt to equity of 11%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 28% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 89 which is a GOOD score indicating consistency in earnings, a RS Rating of 9 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 64 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Bafna Pharmaceuticals Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 41424234221715
Operating Expenses Qtr Cr 37363531191516
Operating Profit Qtr Cr 468432-1
Depreciation Qtr Cr 1121111
Interest Qtr Cr 0111000
Tax Qtr Cr 0000000
Net Profit Qtr Cr 265321-1
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 11987
Operating Expenses Annual Cr 10074
Operating Profit Annual in Cr 1611
Depreciation Cr 55
Interest Annual Cr 21
Tax Annual Cr 00
Net Profit Annual Cr 115
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 58
Cash from Investing Activity Annual Cr -7-5
Cash from Financing Annual Activity Cr 10-4
Net Cash Flow Annual Cr 8-2
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 7363
Fixed Assets Annual Cr 4239
Total Non Current Assets Annual Cr 4239
Total Current Assets Annual Cr 8751
Total Assets Annual Cr 13090
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 3127
ROE Annual % 158
ROCE Annual % 1611
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1616
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Bafna Pharmaceuticals Technicals

EMA & SMA

Current Price
₹89.55
1.85 (2.11%)
pointer
  • Bullish Moving Average
  • ___
  • 11
  • Bearish Moving Average
  • ___
  • 5
  • 20 Day
  • ₹86.74
  • 50 Day
  • ₹88.13
  • 100 Day
  • ₹90.08
  • 200 Day
  • ₹94.24
  • 20 Day
  • ₹85.64
  • 50 Day
  • ₹88.98
  • 100 Day
  • ₹90.59
  • 200 Day
  • ₹92.86

Bafna Pharmaceuticals Resistance and Support

PIVOT
₹89.44
Resistance
First Resistance 91.07
Second Resistance 92.58
Third Resistance 94.22
RSI 55.72
MFI 74.92
MACD Single Line -0.54
MACD 0.23
Support
First Resistance 87.92
Second Resistance 86.28
Third Resistance 84.77

Bafna Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 8,776 877,600 100
Week 31,770 3,177,025 100
1 Month 17,127 1,712,681 100
6 Month 6,813 681,285 100

Bafna Pharmaceuticals Result Highlights

Bafna Pharmaceuticals Synopsis

NSE-Medical-Generic Drugs

Bafna Pharmaceutical belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 115.35 Cr. and Equity Capital is Rs. 23.66 Cr. for the Year ended 31/03/2023. Bafna Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 28/03/1995 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24294TN1995PLC030698 and registration number is 030698.
Market Cap 212
Sales 159
Shares in Float 0.26
No of funds
Yield
Book Value 2.88
U/D Vol ratio 0.5
LTDebt / Equity 11
Alpha -0.03
Beta 0.07

Bafna Pharmaceuticals

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 88.74%90%90%90.02%
Foreign Portfolio Investors
Individual Investors 6.87%5.64%5.63%5.61%
Others 4.39%4.36%4.37%4.37%

Bafna Pharmaceuticals Management

Name Designation
Mrs. S Hemalatha Chairperson & Executive Director
Mrs. Akila C Raju Non Exe.Non Ind.Director
Ms. R Chitra Ind. Non-Executive Director
Mr. B Kamlesh Kumar Ind. Non-Executive Director
Mr. P K Sundaresan Ind. Non-Executive Director

Bafna Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Bafna Pharmaceuticals Corporate Action

Date Purpose Remarks
2023-11-09 Quarterly Results
2023-08-11 Quarterly Results
2023-05-27 Audited Results (Revised)
2023-04-07 Others
2023-02-08 Quarterly Results

Bafna Pharmaceuticals FAQs

What is Share Price of Bafna Pharmaceuticals ?

Bafna Pharmaceuticals share price is ₹89 As on 03 December, 2023 | 07:29

What is the Market Cap of Bafna Pharmaceuticals ?

The Market Cap of Bafna Pharmaceuticals is ₹211.8 Cr As on 03 December, 2023 | 07:29

What is the P/E ratio of Bafna Pharmaceuticals ?

The P/E ratio of Bafna Pharmaceuticals is 12.3 As on 03 December, 2023 | 07:29

What is the PB ratio of Bafna Pharmaceuticals ?

The PB ratio of Bafna Pharmaceuticals is 2.9 As on 03 December, 2023 | 07:29

Q2FY23